All Categories / Oncology / Q1 Journals

Q1 Oncology Journals

Browse Q1 Oncology journals and compare the highest impact Oncology journals in our database. Each listing includes key details authors often use when choosing where to submit.

Rankings are based on the latest Journal Impact Factor and quartile data currently available in our journal database.

#1
CC
JIF 232.4
Q1
Hybrid

CA: A Cancer Journal for Clinicians is the flagship journal of the American Cancer Society and reaches oncology specialists, primary care clinicians, and other professionals who interact with patients with cancer. It publishes information about the prevention,...

Identifiers

ISSN 0007-9235
eISSN 1542-4863

Publication Cost

No submission, page, or color fees. Accepted papers are published under a CC-BY-NC-ND Creative Commons license at no charge to the author; an Article Publication Charge applies if authors require a license other than CC-BY-NC-ND.

Publishing Timeline

2 days submission to first decision (median)
#2
NR
JIF 82.2
Q1
Hybrid

Nature Reviews Clinical Oncology is a review journal covering clinical oncology and related advances in cancer diagnosis, management, therapeutics, epidemiology and precision medicine, publishing content such as Review Articles, Comments, Research Highlights a...

Identifiers

ISSN 1759-4774
eISSN 1759-4782

Publication Cost

No fee for publication.

Publishing Timeline

Submission to first editorial decision (median days): 4; Submission to acceptance (median days): 122
#3
NR

NATURE PORTFOLIO

JIF 66.8
Q1
Hybrid

Nature Reviews Cancer is a journal in the Nature Reviews portfolio covering cancer research and oncology, publishing article formats including Review Articles, Progress articles, Comments, Research Highlights, Journal Club, Expert Recommendations and Tools of...

Identifiers

ISSN 1474-175X
eISSN 1474-1768

Publication Cost

Institutional online access is available for institutions and organizations to purchase through a Springer Nature institutional licence.
#4
AO
JIF 65.4
Q1
Hybrid

Annals of Oncology is the official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology. It publishes innovative cancer treatments and translational work related to oncology and precision medicine, with particular f...

Identifiers

ISSN 0923-7534
eISSN 1569-8041

Publication Cost

This journal has no page charges; open access publishing options are available.

Publishing Timeline

3 days submission to first decision; 45 days submission to acceptance for accepted papers (median)
#5
CC

CELL PRESS

JIF 44.5
Q1
Hybrid

Cancer Cell advances a systemic understanding of cancer as a dynamic interplay between tumor cells, microenvironment, microbiota, nervous system, and host physiology. It bridges foundational discoveries and clinical innovation through bidirectional translation...

Identifiers

ISSN 1535-6108
eISSN 1878-3686

Publication Cost

Article publishing charge: $10,400 for open access publication.

Publishing Timeline

Median 5 days to first editorial decision; median 23 days from acceptance to online publication.
#6
JO

LIPPINCOTT WILLIAMS & WILKINS

JIF 41.9
Q1
Hybrid

Journal of Clinical Oncology is an ASCO journal covering clinical oncology research and publishing article types including original reports, clinical trial updates, special articles, correspondence, rapid communications, and ASCO special articles.

Identifiers

ISSN 0732-183X
eISSN 1527-7755

Publication Cost

A submission fee is mentioned for Case Reports submitted to Journal of Clinical Oncology and not refunded if withdrawn.

Publishing Timeline

Published three times per month — a total of 36 issues per year.
#7
JO
JIF 40.4
Q1
Open

First launched in 2008, the Journal of Hematology & Oncology encompasses all aspects of hematology and oncology. It is a peer reviewed, open access journal and the official journal of the Chinese American Hematologist and Oncologist Network (CAHON), publishing...

Identifiers

eISSN 1756-8722

Publication Cost

£3690.00 GBP / $5190.00 USD / €4490.00 EUR APC

Publishing Timeline

Submission to first decision (median): 8 days
#8
LO

Elsevier BV

JIF 35.9
Q1
Hybrid

The Lancet Oncology is a clinical oncology journal publishing peer reviewed original research, especially reports from clinical trials, as well as reviews, comment and opinion, weekly news, and Commissions. It covers international issues relevant to clinical c...

Identifiers

ISSN 1470-2045
eISSN 1474-5488

Publication Cost

USD 8,810 APC for The Lancet Oncology as of Jan 1, 2026.

Publishing Timeline

2 days submission to first decision; 34 days submission to decision after review; 34 days submission to acceptance; 80 days acceptance to online publication
#9
MC

BioMed Central

JIF 33.9
Q1
Open

Molecular Cancer is an internationally recognized journal focused on how basic cancer research drives advances in cancer prevention, diagnostics, and treatment. It is ranked in the top 25% in the Oncology category of Journal Citation Reports and welcomes submi...

Identifiers

eISSN 1476-4598

Publication Cost

APC: £3690.00 GBP / $5290.00 USD / €4390.00 EUR, plus VAT or local taxes where applicable.

Publishing Timeline

Submission to first decision (median): 3 days; less than 7 days time-to-first-decision
#10
CD

American Association for Cancer Research

JIF 33.3
Q1
Closed

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and R...

Identifiers

ISSN 2159-8274
eISSN 2159-8290

Publication Cost

Publication involves a base publication fee and an additional fee for each display item; authors without financial support may apply for a waiver of the fixed publication fee at submission.

Publishing Timeline

Decisions are typically returned within 35 days of submission; accepted author manuscripts are usually posted OnlineFirst within 48 hours following formal acceptance.
#11
NC

NATURE PORTFOLIO

JIF 28.5
Q1
Hybrid

Nature Cancer is a cancer research journal publishing Articles, Review Articles, Perspectives, News & Views, Research Briefings, News Features, Editorials and other content across cancer biology, clinical oncology, immunotherapy, diagnostics and related fields...

Identifiers

eISSN 2662-1347

Publication Cost

Some non-primary article types are not eligible for Open Access and can only be published using the subscription-based publishing route.

Publishing Timeline

Research articles are published as soon as they are ready and can appear online weeks before assignment to a specific issue.
#12
CC
JIF 24.9
Q1
Open

Cancer Communications is an open access, peer-reviewed online journal published in association with Sun Yat-sen University Cancer Center, covering basic, clinical, and translational cancer research, including clinical trials, epidemiology, molecular and cellul...

Identifiers

eISSN 2523-3548

Publishing Timeline

Rapid publication
#13
JO
JIF 20.8
Q1
Hybrid

Journal of Thoracic Oncology is the official journal of the International Association for the Study of Lung Cancer and the primary educational and informational publication for prevention, detection, diagnosis, and treatment of thoracic malignancies. It emphas...

Identifiers

ISSN 1556-0864
eISSN 1556-1380

Publication Cost

Hybrid journal with open access content; publication cost not specified

Publishing Timeline

4 days from submission to first decision; 5 days from acceptance to online publication
#14
JO

American Medical Association

JIF 20.1
Q1
Closed

JAMA Oncology is a JAMA Network journal focused on oncology research, opinion, and clinical review and education content. The journal publishes article types including Research, Research Letters, Brief Reports, Viewpoints, Invited Commentaries, Reviews, and Cl...

Identifiers

ISSN 2374-2437
eISSN 2374-2445

Publication Cost

Buy article access: $45.00; subscription required for full journal access.

Publishing Timeline

Median time to first decision is 3 days and 33 days with review. All articles are published online first.
#15
TI

Elsevier BV

JIF 17.5
Q1
Hybrid

Trends in Cancer is a member of the Trends review journals that publishes concise expert commentary on frontline research topics and advances in cancer discovery and medicine. It serves scientists, clinicians, policy makers, patients, and advocates with multid...

Identifiers

ISSN 2405-8033
eISSN 2405-8025

Publication Cost

Article Publishing Charges may be fully covered or discounted through institutional or consortial open access agreements.

Publishing Timeline

2 days submission to first decision; 54 days submission to acceptance
#16
CR

American Association for Cancer Research

JIF 16.6
Q1
Open

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal that publishes clinical, translational, and basic research on hepatocellular carcinoma, including signaling pathways, molecular tumor classification, therapies, rad...

Identifiers

ISSN 0008-5472
eISSN 1538-7445

Publication Cost

Publication involves a base publication fee and an additional fee for each display item; authors may apply for a waiver of the fixed publication fee if no financial support exists.

Publishing Timeline

Accelerated Publication
#17
JO
JIF 16.4
Q1
Closed

The Journal of the National Comprehensive Cancer Network publishes oncology-focused content including original research, reviews, NCCN Guidelines, and NCCN Guidelines Insights for practicing clinicians.

Identifiers

ISSN 1540-1405
eISSN 1540-1413

Publishing Timeline

Blinded peer review may take up to 6–8 weeks, depending on reviewer availability and response time.
#18
SI
JIF 15.7
Q1
Hybrid

Seminars in Cancer Biology is a review journal focused on developments in molecular oncology. Each issue is thematic, covers topics of interest to cancer biologists ranging from genetic and molecular causes of cancer to molecular bases of potential therapies,...

Identifiers

ISSN 1044-579X
eISSN 1096-3650

Publication Cost

Open Access APC: USD 5,960 (excluding taxes); subscription publication: no publication fee charged to authors.

Publishing Timeline

6 days to first decision; 50 days to decision after review; 117 days to acceptance; 4 days from acceptance to first online publication.
#19
EH
JIF 13.5
Q1
Open

Experimental Hematology & Oncology publishes preclinical, basic, patient-oriented and translational research in all areas of hematology and oncology. The journal serves as an international platform for laboratory findings and publishes clinical trials with neg...

Identifiers

eISSN 2162-3619

Publication Cost

Authors are asked to pay an open access fee for open access publication; article processing charges and book processing charges apply.

Publishing Timeline

Time to first decision of less than 30 days; submission to first decision (median) 2 days.
#20
Le

Springer Nature

JIF 13.4
Q1
Hybrid

Leukemia is a leading journal covering all aspects of the research and treatment of leukemia and allied diseases.

Identifiers

ISSN 0887-6924
eISSN 1476-5551

Publication Cost

Full Article / Review: £3790.00/$5390.00/€4390.00; Letter / Correspondence / Perspective: £2,150.00/$3,235.00/€2,635.00

Publishing Timeline

Submission to first editorial decision (median days): 3; Submission to acceptance (median days): 110
#21
Ne

Oxford University Press

JIF 13.4
Q1
Hybrid

Neuro-Oncology is a medical oncology and neurology journal published on behalf of the Society for Neuro-Oncology. It reports a 2024 Impact Factor of 13.4 and a 2024 CiteScore of 30.2, and offers publication under either a standard licence or an open access lic...

Identifiers

ISSN 1522-8517
eISSN 1523-5866

Publication Cost

Standard licence has no licence charge. Open access publication requires an APC. Flat publication fee for certain non-open access article types: $800 for EANO, SNO, or ASNO society members and $1000 for non-society members. Colour charges are USD 600 per colour figure.

Publishing Timeline

Papers will normally be reviewed within 3-4 weeks of submission. Page proofs should be returned within 2 working days.
#22
JC
JIF 12.8
Q1
Open

JACC: CardioOncology is an open access specialist journal in the JACC family that advances cardiovascular care of cancer patients through innovative science and evidence-based knowledge. It publishes pre-clinical, translational, and clinical research, as well...

Identifiers

ISSN 2666-0873
eISSN 2666-0873

Publication Cost

Article Publishing Charge: USD 4410 for full length articles and USD 1764 for short communications, excluding taxes.

Publishing Timeline

For expedited review, the editors commit to a decision regarding suitability for expedited publication processing within 2 days and an initial decision within 14 days.
#23
JO

Journal of Experimental & Clinical Cancer Research publishes multidisciplinary research on basic, clinical and translational oncology studies. It is ranked in the first quartile of the oncology category in Journal Citation Reports and operates on an open acces...

Identifiers

eISSN 1756-9966

Publication Cost

£3190.00 GBP / $4490.00 USD / €3790.00 EUR APC; subject to VAT or local taxes where applicable.

Publishing Timeline

First decision after submission within 30 days; submission to first decision (median): 3 days.
#24
BC

Springer Nature

JIF 11.6
Q1
Open

Blood Cancer Journal is a peer-reviewed fully open access journal dedicated to publishing articles related to hematologic malignancies and related disorders.

Identifiers

ISSN 2044-5385
eISSN 2044-5385

Publication Cost

Original Research: £3690.00/$5490.00/€4390.00; Letter / Correspondence / Comment: £1215.00/$1675.00/€1515.00, subject to VAT or local taxes where applicable.

Publishing Timeline

Submission to first editorial decision (median days): 5; submission to acceptance (median days): 76.
#25
BR

BioMed Central

JIF 11.5
Q1
Open

Biomarker Research encompasses every aspect of biomarker investigation across biomedical disciplines, including identification and validation of biomarkers in drug development and in disease diagnosis, treatment, prognosis, and prevention. It is a peer-reviewe...

Identifiers

eISSN 2050-7771

Publication Cost

APC: £2890.00 GBP / $4090.00 USD / €3190.00 EUR, plus VAT or local taxes where applicable.

Publishing Timeline

Submission to first decision (median): 11 days
#26
BC

American Association for Cancer Research

JIF 11.5
Q1
Hybrid

Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases.

Identifiers

ISSN 2643-3230
eISSN 2643-3249

Publication Cost

Manuscript submission fee $35; base publication fee $2500; display item fee $250 per item; open access APC $7000 for CC BY-NC-ND or $8000 for CC BY.

Publishing Timeline

Accepted manuscripts are published OnlineFirst usually within days of acceptance.
#27
JF

The Journal for ImmunoTherapy of Cancer is an open access, peer-reviewed journal and the official journal of the Society for Immunotherapy of Cancer. It publishes research, literature reviews, position papers, practice guidelines, and case studies across tumor...

Identifiers

eISSN 2051-1426

Publication Cost

Article Processing Charges apply; SITC members receive a 25% discount on APCs on papers where they serve as first, last, or corresponding author.

Publishing Timeline

Time to first decision without review: 8 days (median); time to first decision with review: 45 days (median); time from acceptance to publication: 22 days (median)
#28
CT
JIF 10.5
Q1
Hybrid

Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.

Identifiers

ISSN 0305-7372
eISSN 1532-1967

Publication Cost

Article publishing charge applies for open access articles; amount not specified.

Publishing Timeline

4 days from submission to first decision
#29
CC

American Association for Cancer Research

JIF 10.2
Q1
Closed

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogeno...

Identifiers

ISSN 1078-0432
eISSN 1557-3265

Publication Cost

Publication involves a base publication fee and an additional fee for each display item; authors may apply for a waiver of the fixed publication fee if no financial support exists.

Publishing Timeline

Published twice a month, one volume/year.
#30
CL

Elsevier BV

JIF 10.1
Q1
Hybrid

Cancer Letters is an international journal providing a forum for original and pertinent contributions in cancer research. It considers full-length articles and Mini Reviews in the broad area of basic and translational oncology, with special issues highlighting...

Identifiers

ISSN 0304-3835
eISSN 1872-7980

Publication Cost

Open Access APC: USD 4,710 (excluding taxes). Subscription: no publication fee charged to authors.

Publishing Timeline

3 days submission to first decision; 30 days submission to decision after review; 92 days submission to acceptance; 2 days acceptance to first online publication.
#31
JO
JIF 9.4
Q1
Open

The Journal of the National Cancer Center (JNCC) is a peer-reviewed, fully open-access journal launched in March 2021 that publishes high-quality articles across all areas of cancer research, including cancer biology, epidemiology, prevention, detection, diagn...

Identifiers

ISSN 2667-0054
eISSN 2667-0054

Publication Cost

Article Publishing Charge: USD 2700 excluding taxes for all articles.

Publishing Timeline

1 day submission to first decision; 56 days submission to decision after review; 141 days submission to acceptance; 39 days acceptance to online publication
#32
EU
JIF 9.3
Q1
Hybrid

European Urology Oncology is the official journal of the European Association of Urology focused on genitourinary malignancies. It publishes high quality clinical, basic, and translational research with a multidisciplinary approach spanning urology, medical on...

Identifiers

eISSN 2588-9311

Publication Cost

USD 4190 APC for all open access articles, excluding taxes; no open access publication fee for subscription articles.

Publishing Timeline

3 days submission to first decision; 24 days submission to decision after review; 71 days submission to acceptance
#33
LC

Karger Publishers

JIF 9.1
Q1
Hybrid

Liver Cancer publishes clinical and translational research on the causes, mechanisms, prevention, surveillance, diagnosis, and treatment of liver malignancy in humans and experimental models, including molecular targeted therapy, in the form of original and re...

Identifiers

ISSN 2235-1795
eISSN 1664-5553

Publication Cost

Article Processing Charges (APCs) apply for Gold Open Access and Open Access options in hybrid journals; waivers and discounts are available for authors without means.

Publishing Timeline

Avg. Time to Final Decision: 5 weeks
#34
CA

Springer Science+Business Media

JIF 8.7
Q1
Hybrid

Cancer and Metastasis Reviews publishes reviews on recent developments in the biology and treatment of malignant disease, with a focus on the molecular and cellular biology of cancer metastasis and tumor progression, and presents expert contributions on a sing...

Identifiers

ISSN 0167-7659
eISSN 1573-7233

Publication Cost

Open access APC: £2590.00 GBP / $3890.00 USD / €2990.00 EUR; subscription publication: no APC.

Publishing Timeline

Submission to first decision (median): 8 days
#35
CB

Chinese Anti-Cancer Association

JIF 8.4
Q1
Open

Cancer Biology & Medicine is dedicated to reporting the latest advances in cancer research around the world by presenting high quality articles, especially on translational cancer research, to bridge the gap between bench and bedside. The journal promotes acad...

Identifiers

ISSN 2095-3941
eISSN 2095-3941

Publication Cost

Article processing charges may be required after editorial acceptance; journal-specific APCs vary by journal.

Publishing Timeline

Journals may publish the "Just Accepted" version immediately after acceptance.
#36
BE

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer covers the biology and biochemistry of cancer, with emphasis on oncogenes and tumor suppressor genes, cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mec...

Identifiers

ISSN 0304-419X
eISSN 1879-2561

Publication Cost

Open access APC: USD 4,820 excluding taxes; subscription publication: no publication fee charged to authors.

Publishing Timeline

9 days submission to first decision; 71 days submission to decision after review; 132 days submission to acceptance; 3 days acceptance to first online publication.
#37
EO

Elsevier BV

JIF 8.3
Q1
Open

ESMO Open is the European Society for Medical Oncology's online-only, peer-reviewed open access journal covering all disciplines of oncology, with a focus on innovative clinical and translational cancer research. It publishes medical research and educational c...

Identifiers

eISSN 2059-7029

Publication Cost

Article Publishing Charge: USD 4310 excluding taxes for all articles; 30% discount for eligible corresponding authors who are members of specified oncology societies.

Publishing Timeline

3 days submission to first decision; 86 days submission to acceptance
#38
CI
Cancer Immunology Research

American Association for Cancer Research

JIF 8.2
Q1
Closed

Identifiers

ISSN 2326-6066
eISSN 2326-6074
Profile coming soon
#39
NP

NATURE PORTFOLIO

JIF 8
Q1
Open

npj Precision Oncology is a Nature Portfolio journal in the npj Series, published in partnership with The Hormel Institute, featuring open access research, reviews, comments, and special collections in precision oncology.

Identifiers

eISSN 2397-768X

Publication Cost

Original Research: £3190.00 / $4290.00 / €3490.00; Brief Communication, Perspective, Review, Comment, Protocol, Case Report: £1255.00 / $1780.00 / €1420.00; VAT or local taxes may apply.

Publishing Timeline

Submission to first editorial decision (median): 18 days; submission to acceptance (median): 164 days.
#40
Br

Elsevier BV

JIF 7.9
Q1
Open

The Breast is a multidisciplinary open access journal for researchers and clinicians focusing on translational and clinical research for the advancement of breast cancer prevention, diagnosis, and treatment of all stages. It publishes original research article...

Identifiers

ISSN 0960-9776
eISSN 1532-3080

Publication Cost

Article Publishing Charge: USD 3770 for Original Research Articles and Reviews; USD 1670 for Short Communications, Debates, Viewpoints, and Case Reports.

Publishing Timeline

13 days submission to first decision; 55 days submission to decision after review; 89 days submission to acceptance; 2 days acceptance to online publication
#41
Ne

Elsevier BV

JIF 7.7
Q1
Open

Neoplasia is an open access oncology journal that publishes novel investigations across all areas of cancer research, including molecular and genetic findings related to the neoplastic phenotype as well as laboratory and clinical studies on risk assessment, pr...

Identifiers

ISSN 1476-5586
eISSN 1476-5586

Publication Cost

Article Publishing Charge: USD 3790 excluding taxes for all articles.

Publishing Timeline

3 days submission to first decision; 57 days submission to decision after review; 80 days submission to acceptance; 9 days acceptance to online publication
#42
NB

NATURE PORTFOLIO

JIF 7.6
Q1
Open

npj Breast Cancer is a journal in the npj Series focused on breast cancer research and published in partnership with the Breast Cancer Research Foundation.

Identifiers

eISSN 2374-4677

Publication Cost

Authors pay an article processing charge (APC); APC details and discretionary waiver information are provided via the journal's article processing charges page.

Publishing Timeline

Submission to first editorial decision: 10 median days; submission to acceptance: 156 median days.
#43
On
Oncogene

Springer Nature

JIF 7.3
Q1
Hybrid

Identifiers

ISSN 0950-9232
eISSN 1476-5594
Profile coming soon
#44
JO
JIF 7.2
Q1
Hybrid

JNCI: Journal of the National Cancer Institute is a peer-reviewed oncology and cancer sciences journal that has published for eight decades and publishes manuscripts describing novel findings of significance in cancer research.

Identifiers

ISSN 0027-8874
eISSN 1460-2105

Publication Cost

No license charge for standard publication; open access publication requires an open access charge.

Publishing Timeline

2025 median days from acceptance to publication: 22 days
#45
EJ
JIF 7.1
Q1
Closed

The European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. It publishes original research, rev...

Identifiers

ISSN 0959-8049
eISSN 1879-0852

Publication Cost

Article publishing charge (APC) applies for open access articles if the manuscript is accepted.

Publishing Timeline

Proof corrections are requested within two days.
#46
Bi

Adis, Springer Healthcare

JIF 6.9
Q1
Hybrid

BioDrugs is a hybrid journal covering the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease, serving R&D professionals and clinicians interested in biologic therapies.

Identifiers

ISSN 1173-8804
eISSN 1179-190X

Publication Cost

Open access APC: £3790.00 GBP / $5490.00 USD / €4490.00 EUR; subscription publishing: no APC charges apply.

Publishing Timeline

Submission to first decision (median): 7 days; for original research articles under the rapid publication model, peer review decision within 2 weeks of submission and online publication within 4 weeks of acceptance.
#47
BJ
JIF 6.8
Q1
Hybrid

British Journal of Cancer publishes discovery, translational, and clinical cancer research across the broad spectrum of oncology.

Identifiers

ISSN 0007-0920
eISSN 1532-1827

Publication Cost

Full Article / Review: £3790.00 / $5490.00 / €4490.00; Other article types: £3400.00 / $4580.00 / €3695.00

Publishing Timeline

Submission to first editorial decision (median days): 6; Submission to acceptance (median days): 170
#48
CA

Springer Science+Business Media

JIF 6.8
Q1
Open

Clinical and Translational Medicine is an open access journal focused on accelerating the translation of preclinical research to clinical application and communication between basic and clinical scientists. It emphasizes a bench-to-bedside approach and welcome...

Identifiers

ISSN 2001-1326
eISSN 2001-1326

Publication Cost

Open access article publication charge (APC) applies; institutional or funder payment may cover the APC.

Publishing Timeline

Submission to first decision (median): 7 days; submission to acceptance (median): 105 days; acceptance to publication (median): 15 days.
#49
IJ

International Journal of Radiation Oncology, Biology, Physics (IJROBP), known as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and education and health policy relat...

Identifiers

ISSN 0360-3016
eISSN 1879-355X

Publication Cost

USD 4130 excluding taxes for open access articles; no open access publication fee for subscription articles.

Publishing Timeline

16 days from submission to first decision (median)
#50
On
Oncogenesis

SPRINGERNATURE

JIF 6.4
Q1

Identifiers

ISSN 2157-9024
eISSN 2157-9024
Profile coming soon
#51
CJ
Chinese Journal Of Cancer Research

CHINESE JOURNAL CANCER RESEARCH CO

JIF 6.3
Q1

Identifiers

ISSN 1000-9604
eISSN 1993-0631
Profile coming soon
#52
On

Landes Bioscience

JIF 6.3
Q1
Open

OncoImmunology is a dynamic, high-profile, open access journal covering tumor immunology and immunotherapy, including basic and translational studies in solid and hematological malignancies, immune responses against cancer, cancer immunoediting and immune evas...

Identifiers

ISSN 2162-402X
eISSN 2162-402X

Publication Cost

Article Publishing Charge (APC) required for open access publication; institutional agreements, discounts, and waivers may reduce or cover the APC

Publishing Timeline

3 days avg. from submission to first decision; 47 days avg. from submission to first post-review decision; 15 days avg. from acceptance to online publication
#53
RC
Radiology-imaging Cancer

RADIOLOGICAL SOC NORTH AMERICA (RSNA)

JIF 6.3
Q1

Identifiers

ISSN 2638-616X
eISSN 2638-616X
Profile coming soon
#54
AR
Annual Review Of Cancer Biology

ANNUAL REVIEWS

JIF 6.1
Q1

Identifiers

ISSN 2472-3428
eISSN 2472-3428
Profile coming soon
#55
CC
JIF 6
Q1
Open

Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro,...

Identifiers

eISSN 1475-2867

Publication Cost

APC: £2490.00 GBP / $3290.00 USD / €2790.00 EUR, plus VAT or local taxes where applicable.

Publishing Timeline

Submission to first decision (median): 38 days
#56
PC
Prostate Cancer And Prostatic Diseases

SPRINGERNATURE

JIF 5.8
Q1

Identifiers

ISSN 1365-7852
eISSN 1476-5608
Profile coming soon
#57
BC
JIF 5.6
Q1
Open

Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal that publishes basic and translational studies as well as clinical trials on breast cancer. It encourages original and review articles on breast cancer treatment, includ...

Identifiers

ISSN 1465-5411
eISSN 1465-542X

Publication Cost

Article processing charges (APCs) vary by journal.

Publishing Timeline

Offers Accelerated Publication.
#58
CR
JIF 5.6
Q1
Hybrid

Critical Reviews in Oncology/Hematology is the official journal of the European School of Oncology and the International Society of Liquid Biopsy. It publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around...

Identifiers

ISSN 1040-8428
eISSN 1879-0461

Publication Cost

Open Access APC: USD 4,180 (excluding taxes); subscription: no publication fee charged to authors.

Publishing Timeline

7 days submission to first decision; 27 days submission to decision after review; 69 days submission to acceptance; 2 days from acceptance to first online publication.
#59
JP
Jco Precision Oncology

LIPPINCOTT WILLIAMS & WILKINS

JIF 5.6
Q1

Identifiers

eISSN 2473-4284
Profile coming soon
#60
MC

American Association for Cancer Research

JIF 5.5
Q1
Closed

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug re...

Identifiers

ISSN 1535-7163
eISSN 1538-8514

Publication Cost

Publication involves a base publication fee and an additional fee for each display item; authors without financial support may apply for a waiver of the fixed publication fee at submission.

Publishing Timeline

First decision after external peer review within 60 days under the manuscript turnaround guarantee for qualifying AACR Member authors.
#61
C&
Cancer & Metabolism

BMC

JIF 5.3
Q1

Identifiers

eISSN 2049-3002
Profile coming soon
#62
MT
Molecular Therapy Oncology

CELL PRESS

JIF 5.3
Q1

Identifiers

eISSN 2950-3299
Profile coming soon
#63
RA
JIF 5.3
Q1
Hybrid

Radiotherapy and Oncology is the Green Journal and the journal of ESTRO, the European Society for Radiotherapy & Oncology. It publishes research in radiation oncology and supports open access publication options.

Identifiers

ISSN 0167-8140
eISSN 1879-0887

Publication Cost

Article Publishing Charge (APC): USD 3770 excluding taxes for all articles published open access; 30% discount for corresponding authors who are members of the European Society for Radiotherapy & Oncology (ESTRO).

Publishing Timeline

Proof corrections are requested within two days.
#64
BM
JIF 5.2
Q1
Hybrid

Bone Marrow Transplantation publishes peer reviewed original research and reviews addressing all aspects of basic biology and clinical use of haemopoietic cell transplantation. It is the official journal of the EBMT.

Identifiers

ISSN 0268-3369
eISSN 1476-5365

Publication Cost

Funder-compliant open access options

Publishing Timeline

Submission to first editorial decision (median days): 3; Submission to acceptance (median days): 93
#65
CD
Cancer Drug Resistance

OAE PUBLISHING INC

JIF 5.2
Q1

Identifiers

eISSN 2578-532X
Profile coming soon
#66
JO
JIF 5.2
Q1
Hybrid

The Journal of Pathology serves as a translational bridge between basic biomedical science and clinical medicine with particular emphasis on tissue-based studies. Published on behalf of the Pathological Society of Great Britain and Ireland, it publishes high-i...

Identifiers

ISSN 0022-3417
eISSN 1096-9896

Publication Cost

No submission, page or handling charges; OnlineOpen open access option; competitive colour charges

Publishing Timeline

4 days submission to first decision (median); first decision time averages just 4 days
#67
OR
Oncology Reviews

FRONTIERS MEDIA SA

JIF 5.2
Q1

Identifiers

ISSN 1970-5565
eISSN 1970-5557
Profile coming soon
#68
Ca
Cancer

WILEY

JIF 5.1
Q1
Hybrid

Identifiers

ISSN 0008-543X
eISSN 1097-0142
Profile coming soon
#69
CI

Springer Science+Business Media

JIF 5.1
Q1
Open

Cancer Immunology, Immunotherapy provides timely open access publication of original discovery and developments in basic and translational research in the field of cancer immunology and immunotherapy. It is an online-only journal and the print ISSN 0340-7004 i...

Identifiers

ISSN 0340-7004
eISSN 1432-0851

Publication Cost

APC: £2990.00 GBP / $4790.00 USD / €3590.00 EUR

Publishing Timeline

Submission to first decision (median): 2 days
#70
GC
Gastric Cancer

SPRINGER

JIF 5.1
Q1

Identifiers

ISSN 1436-3291
eISSN 1436-3305
Profile coming soon
#71
CG

Springer Nature

JIF 5
Q1
Hybrid

Cancer Gene Therapy is a journal focused on gene and cellular therapy for cancer researchers and clinicians.

Identifiers

ISSN 0929-1903
eISSN 1476-5500

Publication Cost

Open access APC: £2,990 / $4,290 / €3,490, plus VAT or local taxes where applicable.

Publishing Timeline

Submission to first editorial decision: 5 median days; submission to acceptance: 138 median days.
#72
CO
Current Oncology Reports

SPRINGER

JIF 5
Q1

Identifiers

ISSN 1523-3790
eISSN 1534-6269
Profile coming soon
#73
BA
Blood And Lymphatic Cancer-targets And Therapy

DOVE MEDICAL PRESS LTD

JIF 4.9
Q1

Identifiers

ISSN 1179-9889
eISSN 1179-9889
Profile coming soon
#74
IJ
JIF 4.9
Q1
Open

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Identifiers

ISSN 1019-6439
eISSN 1791-2423

Publication Cost

Option 1: basic charge up to 5 pages €550 / £500 / $550, each additional page €110 / £100 / $160, color reproduction per page €390 / £340 / $520. Option 2 for International Journal of Oncology: €2,500 / $2,600 for immediate open access.

Publishing Timeline

Published online on: 24 April 2026; 22 April 2026; 21 April 2026; 15 April 2026; 06 April 2026; 30 March 2026; 27 April 2026.
#75
CN
Cancer Nanotechnology

SPRINGER WIEN

JIF 4.8
Q1

Identifiers

ISSN 1868-6958
eISSN 1868-6966
Profile coming soon
#76
CO
Cellular Oncology

SPRINGER

JIF 4.8
Q1

Identifiers

ISSN 2211-3428
eISSN 2211-3436
Profile coming soon
#77
CT
Current Treatment Options In Oncology

SPRINGER

JIF 4.7
Q1

Identifiers

ISSN 1527-2729
eISSN 1534-6277
Profile coming soon
#78
IJ
JIF 4.7
Q1
Hybrid

International Journal of Cancer is the official journal of the Union for International Cancer Control with a global readership and over 4,800 submissions a year covering a broad scope of topics in experimental and clinical cancer research. The journal invites...

Identifiers

ISSN 0020-7136
eISSN 1097-0215

Publication Cost

No fee for the first 8 pages; US$150 for each page beyond 8. Open access is available for a fee (APC).

Publishing Timeline

5 days submission to first decision (median)
#79
IJ

The International Journal of Gynecological Cancer (IJGC) serves as the primary educational and informational publication on topics related to the detection, prevention, diagnosis, and treatment of gynecologic malignancies. The content is intended for gynecolog...

Identifiers

ISSN 1048-891X
eISSN 1525-1438

Publication Cost

USD 3800 APC for open access articles, excluding taxes; corresponding authors who are ESGO or IGCS members receive a 25% discount

Publishing Timeline

7 days from submission to first decision
#80
MC
Molecular Cancer Research

AMER ASSOC CANCER RESEARCH

JIF 4.7
Q1

Identifiers

ISSN 1541-7786
eISSN 1557-3125
Profile coming soon
#81
CB
Cancer Biology & Therapy

TAYLOR & FRANCIS INC

JIF 4.6
Q1

Identifiers

ISSN 1538-4047
eISSN 1555-8576
Profile coming soon
#82
EC
Endocrine-related Cancer

BIOSCIENTIFICA LTD

JIF 4.6
Q1

Identifiers

ISSN 1351-0088
eISSN 1479-6821
Profile coming soon
#83
JO
Jco Oncology Practice

LIPPINCOTT WILLIAMS & WILKINS

JIF 4.6
Q1

Identifiers

ISSN 2688-1527
eISSN 2688-1535
Profile coming soon
#84
CE

BioMed Central

JIF 4.4
Q1
Open

Clinical Epigenetics is an open access journal covering the broad spectrum of epigenetics research from basic research to innovations in therapeutic treatments, with a focus on epigenetic principles and mechanisms as applied to human development, disease, diag...

Identifiers

ISSN 1868-7075
eISSN 1868-7083

Publication Cost

APC: £2790.00 GBP / $3890.00 USD / €3190.00 EUR, plus VAT or local taxes where applicable.

Publishing Timeline

Submission to first decision (median): 7 days
#85
GO
Gynecologic Oncology

ACADEMIC PRESS INC ELSEVIER SCIENCE

JIF 4.1
Q1

Identifiers

ISSN 0090-8258
eISSN 1095-6859
Profile coming soon
#86
NA
Neuro-oncology Advances

OXFORD UNIV PRESS

JIF 4.1
Q1

Identifiers

eISSN 2632-2498
Profile coming soon
#87
HO
Hematological Oncology

WILEY

JIF 3.9
Q1

Identifiers

ISSN 0278-0232
eISSN 1099-1069
Profile coming soon
#88
OO

Elsevier BV

JIF 3.9
Q1
Hybrid

Oral Oncology is an international interdisciplinary journal related to head and neck oncology that publishes original research, clinical trials, review articles, editorials, and commentaries on the etiopathogenesis, epidemiology, prevention, clinical features,...

Identifiers

ISSN 1368-8375
eISSN 1879-0593

Publication Cost

Open Access Article Publishing Charge (APC): USD 4,540 (excluding taxes); subscription publication has no publication fee charged to authors

Publishing Timeline

4 days submission to first decision; 45 days submission to decision after review; 9 days acceptance to online publication
#89
JO
Journal Of Gynecologic Oncology

KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY

JIF 3.7
Q1

Identifiers

ISSN 2005-0380
eISSN 2005-0399
Profile coming soon
#90
BC
Breast Cancer

SPRINGER JAPAN KK

JIF 2.9
Q1

Identifiers

ISSN 1340-6868
eISSN 1880-4233
Profile coming soon
#91
EJ
JIF 2.7
Q1
Hybrid

The European Journal of Oncology Nursing is an international journal that publishes research of direct relevance to patient care, nurse education, management and policy development. EJON is the official journal of the European Oncology Nursing Society and publ...

Identifiers

ISSN 1462-3889
eISSN 1532-2122

Publication Cost

Open Access Article Publishing Charge (APC): USD 3,750 (excluding taxes). Subscription: No publication fee charged to authors.

Publishing Timeline

11 days submission to first decision; 65 days submission to decision after review; 78 days submission to acceptance; 2 days from acceptance to first online publication.
#92
CN

LIPPINCOTT WILLIAMS & WILKINS

JIF 2.5
Q1
Closed

Cancer Nursing is a Lippincott journal with open access licensing options and standard copyright and permissions policies for final published articles and final peer-reviewed manuscripts.

Identifiers

ISSN 0162-220X
eISSN 1538-9804

Publication Cost

No fee for standard publication; optional open access publication is available with an article processing charge paid within 30 days after the accepted article is transmitted to production.

Publishing Timeline

Accepted, copyedited manuscripts may be published electronically ahead of print as Early Access Articles.
Preparing a manuscript for a high-impact journal?

Livewrite works inside Microsoft Word to help researchers write, edit, cite, review, and format manuscripts for journal submission.